The introduction of new assays for a diagnostic platform typically expands the product's marketability and utility, which can lead to increased sales. As Zomedica is directly involved in the production and distribution of these assays, this expansion is highly relevant and important to the company's performance. The confidence score reflects the general positive impact of product expansion on a company's financials, though market reception and actual sales performance remain to be seen.